Your verdict
Your page is mostly your own.
Most of what you say, Medscout and the rest of your set do not. You're less same than 362 of the 366 SaaS sites scored (SaaS avg 56).
Each named site is scored the same way, against the other 1 in this set, so its tick means the same as your marker. The dashed line is the frozen benchmark average.
Less same than average
The average SaaS site scores 56; you scored 17.
You are 39 points less same than the average SaaS site.
Closest overlap: Medscout
Of the 1 site you named, Medscout echoes the most of what your page says: 17% of it, weighted by placement. Scored the same way you were, against the rest of the set, Medscout's own Sameness Index is 26. Those are different measures: the first is overlap with your page, the second is how same Medscout's whole page is.
Medscout is the competitor you sound most like.
Room to own more
26% of your claim space is ownable: unique, relevant, and hard to copy. 11 of those claims sit in body copy, where few readers reach them.
26% is ownable, and 11 buried opportunities could help you stand out more.
Three changes worth testing first.
Chosen by rule from the comparison with Medscout: the shared claim taking your most prominent space, then the claims only you make that sit too low on the page to be read. Each one links to its claim card.
- “I wish I had this when I was a rep”
Medscout all say it too. Buyers may still need it, but shared ground cannot carry your section — move it lower and give that space to something only you can say.
Table stakesMost of the set says this too. - “Seeing payer mix and procedure volume at the physician level ensures reps don't spend time on accounts that aren't a fit”
Nobody in the set says this. It sits in body copy, where few readers reach it — worth testing higher up the page; only buyers can tell you whether it lands.
SurfaceYours alone. Test it higher up. - “AcuityMD Quoting has removed bottlenecks and given salespeople ownership over accounts (AnX Robotica)”
A claim that is yours alone, filed in body copy. Try it where it will be read before the shared claims are, and let buyers tell you if it moves them.
SurfaceYours alone. Test it higher up.
Try these changes, then test them with real buyers.
This measures overlap. Whether buyers notice is a different question, and only they can answer it.
What you can own
Claims only you make, that buyers weigh, and that competitors can’t easily copy.
26% of your page’s claim space is yours to keep.
Why this is not 100 minus the Sameness Index
The index is a weighted composite across six categories, including page structure and visuals. This bar is measured on your claims alone, weighted by where each one sits on the page. Different denominators, so the two never add to 100 and are not meant to.
Already leading with · 3
- AI users are 3x more likely to hit quota
“AI users are 3x more likely to hit quota”
- Purpose-built platform for MedTech commercial teams
“Built for MedTech”
- Trusted by 500+ medical device companies
“Trusted by 500+ medical device companies”
Buried in body copy · 11
- Achieved 97% forecast accuracy
“97% forecast accuracy (Route 92 Medical)”
- Customers report large revenue increases after adopting
“We've increased revenue dramatically every year since launching in the U.S. (Kuros Biosciences)”
- Data replaces gut feel with defensible decisions
“AcuityMD gives us the grounding in data we need to justify every decision and the confidence to expand intelligently (Kuros Biosciences)”
- Faster new-rep onboarding
“10x faster onboarding (Route 92 Medical)”
- High rep adoption and daily usage rates
“93% monthly active users (Aerin Medical)”
- Named customer reach and pipeline result metrics
“3,500+ providers and sites of care reached (Aerin Medical)”
- Physician-level payer mix and procedure volume data
“Seeing payer mix and procedure volume at the physician level ensures reps don't spend time on accounts that aren't a fit”
- Quoting removes bottlenecks, gives reps account ownership
“AcuityMD Quoting has removed bottlenecks and given salespeople ownership over accounts (AnX Robotica)”
- Reps see daily performance and next actions
“Reps log in each morning and see exactly where they're up or down month-to-date and what to act on (Corza Biosurgery)”
- Saves reps significant administrative hours monthly
“25+ hours per month saved (AnX Robotica)”
- Shortens time from outreach to close
“Faster sales process, fewer weeks from initial outreach to close”
Where you blend in
Territory you spend prominent space on that the set also occupies. Not every line is one to delete — the question is whether it has earned the space, or whether something only you can say should be there instead.
- Commodity · 100%KeepHeropurpose-built for the industry vertical
- “Built for MedTech”
- “AcuityMD helps your team execute with confidence whether launching innovations, expanding territories, or building physician relationships”
You say this 2 different ways.
Medscout all say what they are and who they are for, as every page in a category must. Keep it — it is orientation, not differentiation. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.
They say- Medscout“Medscout provides comprehensive assistance to international patients seeking medical treatment in Germany, Austria and Switzerland”
- Commodity · 100%Table stakesSectioncustomer testimonial
- “I wish I had this when I was a rep”
Medscout all cover this territory. Buyers may need to hear it, but in your section it spends the first impression on shared ground. Nobody else uses your exact words, but everyone is on the ground. Nobody else makes this exact claim, but everyone occupies the territory — lead with the specific, not the generic.
They say- Medscout“Medscout helped me find the right clinic for my father. Highly recommended!”
Claim-by-claim evidence
Every claim on your page (26)
What the columns mean
- Claim
- The grouped claim, then your exact line beneath it.
- Type
- What kind of claim it is: category, segment, outcome, capability, quality or proof.
- Placement
- Where it sits on your page: hero, section or body copy. Hero claims weigh most in the index.
- Same claim
- Share of the competitors making this exact claim. Drives ownership and ownable share.
- Same territory
- Share of the competitors with any claim in the same buyer-facing territory. This is what the index is scored on.
- Sayability
- Whether a competitor could truthfully make the same claim: anyone could, copyable with effort, or hard to copy.
- Relevant
- Whether buyers decide on this. A unique claim nobody buys on is not ownable.
- Ownership
- Commodity: 60% or more of the set says it. Contested: 20–59%. Unique: under 20%, owned when it is also hard to copy.
Tap a column to sort by it; tap again to reverse. Sorted by Same claim, highest first.
AI capability built into the platform “Powered by AcuityAI” | capability | Hero | 0% | 0% | Anyone could say it | Yes | Unique for now |
AI users are 3x more likely to hit quota “AI users are 3x more likely to hit quota” | proof | Hero | 0% | 0% | Copyable with effort | Yes | Unique and owned |
Move faster on best opportunities with aligned teams “Move faster on your best opportunities with every team aligned — now powered by AcuityAI” | outcome | Hero | 0% | 0% | Anyone could say it | Yes | Unique for now |
Purpose-built platform for MedTech commercial teams “Built for MedTech” | category | Hero | 0% | 100% | Copyable with effort | Yes | Unique and owned |
Trusted by 500+ medical device companies “Trusted by 500+ medical device companies” | proof | Hero | 0% | 0% | Copyable with effort | Yes | Unique and owned |
Aligns marketing campaigns with sales opportunity “Align marketing efforts with sales strategy, focus campaigns where the opportunity is greatest, and demonstrate impact on product adoption and growth” | capability | Section | 0% | 0% | Anyone could say it | No | Unique for now |
Better pipeline visibility and forecast accuracy for leaders “Improve pipeline visibility, boost forecast accuracy, and drive consistent revenue growth for sales leaders” | outcome | Section | 0% | 0% | Anyone could say it | Yes | Unique for now |
Drives faster revenue growth and product adoptiongrouping uncertain “Real impact. Faster growth.” | outcome | Section | 0% | 0% | Anyone could say it | Yes | Unique for now |
Industry-leading data delivered in usable format “We deliver industry-leading data in a format reps actually use” | quality | Section | 0% | 0% | Anyone could say it | Yes | Unique for now |
Prioritizes high-value accounts with insights in one place “Prioritize high-value accounts, uncover your best opportunities, and save time by having the insights you need in one place for sales reps” | outcome | Section | 0% | 0% | Anyone could say it | Yes | Unique for now |
Reps spend more time selling, less searching “Spend more time selling and less time searching” | outcome | Section | 0% | 0% | Anyone could say it | Yes | Unique for now |
Reps wish they had had this tool “I wish I had this when I was a rep” | proof | Section | 0% | 100% | Anyone could say it | No | Unique for now |
Supports launches, expansion and physician relationships “AcuityMD helps your team execute with confidence whether launching innovations, expanding territories, or building physician relationships” | capability | Section | 0% | 100% | Anyone could say it | Yes | Unique for now |
Surfaces whitespace and under-penetrated accounts to target “AcuityMD helps sales leaders surface whitespace, prioritize rep activity, and accelerate time-to-close” | capability | Section | 0% | 0% | Anyone could say it | Yes | Unique for now |
Territory mapping and growth planning on market data “Map territories to the highest-value opportunities, spot underperformance early, and support strategic growth planning with accurate market data” | capability | Section | 0% | 0% | Anyone could say it | Yes | Unique for now |
Achieved 97% forecast accuracy “97% forecast accuracy (Route 92 Medical)” | proof | Body | 0% | 0% | Anyone could say it | Yes | Unique for now |
Customers report large revenue increases after adopting “We've increased revenue dramatically every year since launching in the U.S. (Kuros Biosciences)” | proof | Body | 0% | 0% | Anyone could say it | Yes | Unique for now |
Data replaces gut feel with defensible decisions “AcuityMD gives us the grounding in data we need to justify every decision and the confidence to expand intelligently (Kuros Biosciences)” | proof | Body | 0% | 0% | Anyone could say it | Yes | Unique for now |
Faster new-rep onboarding “10x faster onboarding (Route 92 Medical)” | proof | Body | 0% | 0% | Anyone could say it | Yes | Unique for now |
High rep adoption and daily usage rates “93% monthly active users (Aerin Medical)” | proof | Body | 0% | 0% | Anyone could say it | Yes | Unique for now |
Named customer reach and pipeline result metrics “3,500+ providers and sites of care reached (Aerin Medical)” | proof | Body | 0% | 0% | Anyone could say it | Yes | Unique for now |
Physician-level payer mix and procedure volume data “Seeing payer mix and procedure volume at the physician level ensures reps don't spend time on accounts that aren't a fit” | proof | Body | 0% | 0% | Copyable with effort | Yes | Unique and owned |
Quoting removes bottlenecks, gives reps account ownership “AcuityMD Quoting has removed bottlenecks and given salespeople ownership over accounts (AnX Robotica)” | proof | Body | 0% | 0% | Copyable with effort | Yes | Unique and owned |
Reps see daily performance and next actions “Reps log in each morning and see exactly where they're up or down month-to-date and what to act on (Corza Biosurgery)” | proof | Body | 0% | 0% | Anyone could say it | Yes | Unique for now |
Saves reps significant administrative hours monthly “25+ hours per month saved (AnX Robotica)” | proof | Body | 0% | 0% | Anyone could say it | Yes | Unique for now |
Shortens time from outreach to close “Faster sales process, fewer weeks from initial outreach to close” | outcome | Body | 0% | 0% | Anyone could say it | Yes | Unique for now |
- AI capability built into the platform“Powered by AcuityAI”capabilityHerosame claim 0%same territory 0%Anyone could say itUnique for now
- AI users are 3x more likely to hit quota“AI users are 3x more likely to hit quota”proofHerosame claim 0%same territory 0%Copyable with effortUnique and owned
- Move faster on best opportunities with aligned teams“Move faster on your best opportunities with every team aligned — now powered by AcuityAI”outcomeHerosame claim 0%same territory 0%Anyone could say itUnique for now
- Purpose-built platform for MedTech commercial teams“Built for MedTech”categoryHerosame claim 0%same territory 100%Copyable with effortUnique and owned
- Trusted by 500+ medical device companies“Trusted by 500+ medical device companies”proofHerosame claim 0%same territory 0%Copyable with effortUnique and owned
- Aligns marketing campaigns with sales opportunity“Align marketing efforts with sales strategy, focus campaigns where the opportunity is greatest, and demonstrate impact on product adoption and growth”capabilitySectionsame claim 0%same territory 0%Anyone could say itnot a buying criterionUnique for now
- Better pipeline visibility and forecast accuracy for leaders“Improve pipeline visibility, boost forecast accuracy, and drive consistent revenue growth for sales leaders”outcomeSectionsame claim 0%same territory 0%Anyone could say itUnique for now
- Drives faster revenue growth and product adoptiongrouping uncertain“Real impact. Faster growth.”outcomeSectionsame claim 0%same territory 0%Anyone could say itUnique for now
- Industry-leading data delivered in usable format“We deliver industry-leading data in a format reps actually use”qualitySectionsame claim 0%same territory 0%Anyone could say itUnique for now
- Prioritizes high-value accounts with insights in one place“Prioritize high-value accounts, uncover your best opportunities, and save time by having the insights you need in one place for sales reps”outcomeSectionsame claim 0%same territory 0%Anyone could say itUnique for now
- Reps spend more time selling, less searching“Spend more time selling and less time searching”outcomeSectionsame claim 0%same territory 0%Anyone could say itUnique for now
- Reps wish they had had this tool“I wish I had this when I was a rep”proofSectionsame claim 0%same territory 100%Anyone could say itnot a buying criterionUnique for now
- Supports launches, expansion and physician relationships“AcuityMD helps your team execute with confidence whether launching innovations, expanding territories, or building physician relationships”capabilitySectionsame claim 0%same territory 100%Anyone could say itUnique for now
- Surfaces whitespace and under-penetrated accounts to target“AcuityMD helps sales leaders surface whitespace, prioritize rep activity, and accelerate time-to-close”capabilitySectionsame claim 0%same territory 0%Anyone could say itUnique for now
- Territory mapping and growth planning on market data“Map territories to the highest-value opportunities, spot underperformance early, and support strategic growth planning with accurate market data”capabilitySectionsame claim 0%same territory 0%Anyone could say itUnique for now
- Achieved 97% forecast accuracy“97% forecast accuracy (Route 92 Medical)”proofBodysame claim 0%same territory 0%Anyone could say itUnique for now
- Customers report large revenue increases after adopting“We've increased revenue dramatically every year since launching in the U.S. (Kuros Biosciences)”proofBodysame claim 0%same territory 0%Anyone could say itUnique for now
- Data replaces gut feel with defensible decisions“AcuityMD gives us the grounding in data we need to justify every decision and the confidence to expand intelligently (Kuros Biosciences)”proofBodysame claim 0%same territory 0%Anyone could say itUnique for now
- Faster new-rep onboarding“10x faster onboarding (Route 92 Medical)”proofBodysame claim 0%same territory 0%Anyone could say itUnique for now
- High rep adoption and daily usage rates“93% monthly active users (Aerin Medical)”proofBodysame claim 0%same territory 0%Anyone could say itUnique for now
- Named customer reach and pipeline result metrics“3,500+ providers and sites of care reached (Aerin Medical)”proofBodysame claim 0%same territory 0%Anyone could say itUnique for now
- Physician-level payer mix and procedure volume data“Seeing payer mix and procedure volume at the physician level ensures reps don't spend time on accounts that aren't a fit”proofBodysame claim 0%same territory 0%Copyable with effortUnique and owned
- Quoting removes bottlenecks, gives reps account ownership“AcuityMD Quoting has removed bottlenecks and given salespeople ownership over accounts (AnX Robotica)”proofBodysame claim 0%same territory 0%Copyable with effortUnique and owned
- Reps see daily performance and next actions“Reps log in each morning and see exactly where they're up or down month-to-date and what to act on (Corza Biosurgery)”proofBodysame claim 0%same territory 0%Anyone could say itUnique for now
- Saves reps significant administrative hours monthly“25+ hours per month saved (AnX Robotica)”proofBodysame claim 0%same territory 0%Anyone could say itUnique for now
- Shortens time from outreach to close“Faster sales process, fewer weeks from initial outreach to close”outcomeBodysame claim 0%same territory 0%Anyone could say itUnique for now
How this was calculated
Sameness measures how much your claims overlap with the sites compared. It does not measure message quality or whether buyers prefer you.
AI-analyzed: an AI read each page on its own and grouped the claims that say the same thing. No score here was written by a model — every number is computed from those groupings in our own code, with the weights below.
How the score is built
| Category | Weight | Yours | What a high score means |
|---|---|---|---|
Messaging Category framing, who it is for, and the outcome promised | 30% | 22 | The most expensive kind of sameness. A buyer cannot tell what job you do that the others do not. |
Claims Attribute and benefit claims — speed, ease, quality, ROI | 30% | 0 | Every shared claim is a line already read on another tab. Cut the ones nobody owns and spend the space on something they cannot. |
Features Capabilities and functions the page lists | 15% | 18 | Expected in a mature category, and the least alarming of the six. Feature parity is normal; leading with it is the mistake. |
Proof The kinds of evidence offered: customer logos, numbers, testimonials, case studies, badges | 10% | 13 | Same kinds of proof as everyone means the proof stops working as proof. It is scored on the kind of evidence, not on which customers are named. |
Structure Section order, navigation, CTA language and placement | 10% | 34 | The generic SaaS template — hero, logos, three-feature grid, testimonial, CTA. Familiar is not the same as memorable. |
Visual Palette family, imagery style, layout patterns | 5% | 60 | Weighted lowest on purpose: buyers rarely decide on this. Worth knowing, rarely worth fixing first. |
Each site was read on its own first, with no knowledge of the others, so your page gets no benefit of the doubt a competitor’s does not. A category nothing could be measured for drops out and the rest are re-weighted, rather than counted as zero.
What we compared (2 pages read)
What it cannot tell you
The index can find where two pages converge. It cannot say whether a buyer would notice, or which of your reasons to buy actually land. A single check also moves several points between runs, so read the band and the ranking, not the last digit.
Your highest-impact changes
- 1Table stakesYour section copy says “I wish I had this when I was a rep”.
Medscout all say it too. Buyers may still need it, but shared ground cannot carry your section — move it lower and give that space to something only you can say.
- 2Table stakesYour section copy says “AcuityMD helps your team execute with confidence whether launching innovations, expanding territories, or bui…”.
Keep the fact, lose the position: medscout all say it too, and your section is spending its first impression on the same territory as theirs.
- 3Surface“Seeing payer mix and procedure volume at the physician level ensures reps don't spend time on accounts that a…” is yours alone, and buyers weigh it.
Nobody in the set says this. It sits in body copy, where few readers reach it — worth testing higher up the page; only buyers can tell you whether it lands.
- 4Surface“AcuityMD Quoting has removed bottlenecks and given salespeople ownership over accounts (AnX Robotica)” is yours alone, and buyers weigh it.
A claim that is yours alone, filed in body copy. Try it where it will be read before the shared claims are, and let buyers tell you if it moves them.
- 5Surface“97% forecast accuracy (Route 92 Medical)” is yours alone, and buyers weigh it.
No competitor page makes this claim. Today it is in body copy; it is a candidate for the space the table-stakes lines are taking.
- 6Surface“We've increased revenue dramatically every year since launching in the U.S. (Kuros Biosciences)” is yours alone, and buyers weigh it.
The rest of the set has nothing on this ground. Buried in body copy it does no work; higher up it is the one line a comparing buyer cannot find elsewhere.
- 7Surface“AcuityMD gives us the grounding in data we need to justify every decision and the confidence to expand intell…” is yours alone, and buyers weigh it.
Filed in body copy: Nobody in the set says this. It sits in body copy, where few readers reach it — worth testing higher up the page; only buyers can tell you whether it lands.
- 8Surface“10x faster onboarding (Route 92 Medical)” is yours alone, and buyers weigh it.
Filed in body copy: Nobody in the set says this. It sits in body copy, where few readers reach it — worth testing higher up the page; only buyers can tell you whether it lands.
- 9Surface“93% monthly active users (Aerin Medical)” is yours alone, and buyers weigh it.
Filed in body copy: Nobody in the set says this. It sits in body copy, where few readers reach it — worth testing higher up the page; only buyers can tell you whether it lands.
- 10Surface“3,500+ providers and sites of care reached (Aerin Medical)” is yours alone, and buyers weigh it.
Filed in body copy: Nobody in the set says this. It sits in body copy, where few readers reach it — worth testing higher up the page; only buyers can tell you whether it lands.
- 11Surface“Reps log in each morning and see exactly where they're up or down month-to-date and what to act on (Corza Bio…” is yours alone, and buyers weigh it.
Filed in body copy: Nobody in the set says this. It sits in body copy, where few readers reach it — worth testing higher up the page; only buyers can tell you whether it lands.
- 12Surface“25+ hours per month saved (AnX Robotica)” is yours alone, and buyers weigh it.
Filed in body copy: Nobody in the set says this. It sits in body copy, where few readers reach it — worth testing higher up the page; only buyers can tell you whether it lands.
- 13Surface“Faster sales process, fewer weeks from initial outreach to close” is yours alone, and buyers weigh it.
Filed in body copy: Nobody in the set says this. It sits in body copy, where few readers reach it — worth testing higher up the page; only buyers can tell you whether it lands.
The only way to know if it matters.
This report can tell you where your messaging overlaps. It cannot tell you whether a buyer would care, or which of your reasons to buy actually land. Put the page in front of real B2B buyers in your target market and ask them.







